Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Medicare | 104 | 2024 | 6566 | 8.610 |
Why?
|
Primary Health Care | 63 | 2023 | 4557 | 7.360 |
Why?
|
Medicare Part C | 19 | 2024 | 296 | 6.470 |
Why?
|
Fee-for-Service Plans | 36 | 2023 | 694 | 5.120 |
Why?
|
Physicians, Primary Care | 20 | 2024 | 592 | 5.000 |
Why?
|
Reimbursement Mechanisms | 20 | 2020 | 670 | 4.290 |
Why?
|
Physicians | 39 | 2023 | 4567 | 3.640 |
Why?
|
United States | 246 | 2024 | 69872 | 3.190 |
Why?
|
Aortic Aneurysm, Abdominal | 19 | 2019 | 1186 | 3.100 |
Why?
|
Managed Care Programs | 29 | 2016 | 950 | 3.050 |
Why?
|
Health Maintenance Organizations | 18 | 2023 | 642 | 2.790 |
Why?
|
Health Expenditures | 37 | 2023 | 2349 | 2.780 |
Why?
|
Quality of Health Care | 55 | 2023 | 4369 | 2.740 |
Why?
|
Ambulatory Care | 20 | 2023 | 2708 | 2.550 |
Why?
|
Specialization | 17 | 2023 | 776 | 2.520 |
Why?
|
Insurance, Health | 19 | 2022 | 2494 | 2.490 |
Why?
|
Reimbursement, Incentive | 26 | 2021 | 540 | 2.470 |
Why?
|
Referral and Consultation | 20 | 2022 | 3531 | 2.320 |
Why?
|
Health Care Surveys | 34 | 2023 | 2453 | 2.270 |
Why?
|
Community Health Centers | 12 | 2017 | 430 | 2.270 |
Why?
|
Quality Indicators, Health Care | 34 | 2022 | 1831 | 2.200 |
Why?
|
Patient-Centered Care | 14 | 2023 | 1438 | 2.140 |
Why?
|
Quality Assurance, Health Care | 22 | 2011 | 2212 | 2.110 |
Why?
|
Hospitalists | 4 | 2022 | 305 | 2.060 |
Why?
|
Medicare Part D | 4 | 2023 | 328 | 1.990 |
Why?
|
Hospitalization | 26 | 2024 | 10259 | 1.900 |
Why?
|
Group Practice | 10 | 2021 | 149 | 1.890 |
Why?
|
Emergency Service, Hospital | 21 | 2024 | 7658 | 1.710 |
Why?
|
Cost Savings | 17 | 2024 | 925 | 1.700 |
Why?
|
Office Visits | 8 | 2023 | 598 | 1.690 |
Why?
|
Aortic Rupture | 8 | 2016 | 312 | 1.550 |
Why?
|
Physician Assistants | 5 | 2023 | 192 | 1.520 |
Why?
|
Endovascular Procedures | 11 | 2020 | 1980 | 1.500 |
Why?
|
Health Care Reform | 12 | 2018 | 1261 | 1.490 |
Why?
|
Nurse Practitioners | 5 | 2023 | 269 | 1.430 |
Why?
|
Vascular Surgical Procedures | 8 | 2018 | 1476 | 1.420 |
Why?
|
Hospitals | 16 | 2024 | 3954 | 1.410 |
Why?
|
Community Networks | 5 | 2018 | 203 | 1.410 |
Why?
|
Practice Management, Medical | 6 | 2020 | 196 | 1.380 |
Why?
|
Back Pain | 6 | 2017 | 545 | 1.360 |
Why?
|
Aged | 129 | 2024 | 163288 | 1.340 |
Why?
|
Deductibles and Coinsurance | 9 | 2016 | 316 | 1.330 |
Why?
|
Cross-Sectional Studies | 51 | 2024 | 25039 | 1.280 |
Why?
|
Electronic Mail | 3 | 2015 | 213 | 1.280 |
Why?
|
Humans | 318 | 2024 | 744366 | 1.270 |
Why?
|
Patient Protection and Affordable Care Act | 10 | 2022 | 1209 | 1.270 |
Why?
|
Medicine | 14 | 2022 | 946 | 1.250 |
Why?
|
Job Satisfaction | 7 | 2018 | 534 | 1.220 |
Why?
|
Total Quality Management | 7 | 2010 | 274 | 1.210 |
Why?
|
State Health Plans | 6 | 2014 | 216 | 1.160 |
Why?
|
Capitation Fee | 5 | 2017 | 116 | 1.120 |
Why?
|
General Practitioners | 3 | 2017 | 103 | 1.110 |
Why?
|
Patient Readmission | 11 | 2024 | 3116 | 1.080 |
Why?
|
Patient Admission | 6 | 2021 | 1380 | 1.070 |
Why?
|
Insurance Carriers | 4 | 2024 | 157 | 1.050 |
Why?
|
Chronic Disease | 17 | 2023 | 9145 | 1.040 |
Why?
|
Long-Term Care | 3 | 2020 | 607 | 1.030 |
Why?
|
Physician Incentive Plans | 9 | 2014 | 161 | 1.030 |
Why?
|
Healthcare Disparities | 12 | 2021 | 3154 | 1.020 |
Why?
|
Health Services Accessibility | 24 | 2022 | 5135 | 1.010 |
Why?
|
Blood Vessel Prosthesis Implantation | 7 | 2018 | 1391 | 1.010 |
Why?
|
Patient Care | 6 | 2013 | 640 | 1.000 |
Why?
|
Preferred Provider Organizations | 3 | 2023 | 38 | 0.990 |
Why?
|
Headache | 4 | 2017 | 1226 | 0.990 |
Why?
|
Medicaid | 12 | 2021 | 2737 | 0.990 |
Why?
|
Insurance Coverage | 6 | 2020 | 1900 | 0.980 |
Why?
|
Male | 176 | 2024 | 350115 | 0.960 |
Why?
|
Health Care Costs | 10 | 2023 | 3208 | 0.940 |
Why?
|
Female | 181 | 2024 | 380193 | 0.920 |
Why?
|
Analgesics, Non-Narcotic | 3 | 2015 | 366 | 0.900 |
Why?
|
Health Services Misuse | 5 | 2016 | 243 | 0.850 |
Why?
|
Delivery of Health Care | 15 | 2022 | 5321 | 0.850 |
Why?
|
Aged, 80 and over | 56 | 2023 | 57776 | 0.850 |
Why?
|
Health Services Research | 24 | 2021 | 1836 | 0.830 |
Why?
|
National Health Programs | 2 | 2021 | 445 | 0.810 |
Why?
|
Early Termination of Clinical Trials | 1 | 2021 | 68 | 0.800 |
Why?
|
Diabetes Mellitus | 14 | 2021 | 5749 | 0.760 |
Why?
|
Crowding | 1 | 2022 | 145 | 0.750 |
Why?
|
Physicians, Family | 3 | 2017 | 345 | 0.730 |
Why?
|
Myocardial Infarction | 6 | 2024 | 11718 | 0.720 |
Why?
|
Risk Adjustment | 8 | 2020 | 594 | 0.720 |
Why?
|
Clinical Coding | 2 | 2018 | 171 | 0.700 |
Why?
|
Delivery of Health Care, Integrated | 6 | 2017 | 941 | 0.700 |
Why?
|
Models, Economic | 5 | 2020 | 712 | 0.690 |
Why?
|
Insurance Claim Reporting | 2 | 2017 | 163 | 0.690 |
Why?
|
Hospital Mortality | 10 | 2022 | 5316 | 0.670 |
Why?
|
Relative Value Scales | 1 | 2019 | 84 | 0.660 |
Why?
|
Gatekeeping | 1 | 2018 | 45 | 0.660 |
Why?
|
Patient Satisfaction | 16 | 2016 | 3395 | 0.660 |
Why?
|
Dementia | 2 | 2023 | 2518 | 0.650 |
Why?
|
Retrospective Studies | 47 | 2023 | 77460 | 0.640 |
Why?
|
Bed Occupancy | 1 | 2018 | 41 | 0.640 |
Why?
|
Workload | 2 | 2022 | 849 | 0.640 |
Why?
|
Physician-Patient Relations | 11 | 2016 | 3229 | 0.630 |
Why?
|
Health Services | 2 | 2014 | 758 | 0.630 |
Why?
|
Certification | 5 | 2022 | 423 | 0.600 |
Why?
|
Internal Medicine | 6 | 2022 | 1009 | 0.600 |
Why?
|
Insurance Claim Review | 8 | 2021 | 720 | 0.600 |
Why?
|
Preventive Health Services | 5 | 2016 | 575 | 0.600 |
Why?
|
Home Care Services | 1 | 2024 | 606 | 0.600 |
Why?
|
Contracts | 5 | 2022 | 60 | 0.590 |
Why?
|
Professional Practice Location | 1 | 2017 | 59 | 0.590 |
Why?
|
Intensive Care Units | 4 | 2020 | 3680 | 0.590 |
Why?
|
Income | 5 | 2022 | 1913 | 0.580 |
Why?
|
Clinical Competence | 12 | 2018 | 4687 | 0.580 |
Why?
|
Developed Countries | 4 | 2024 | 437 | 0.570 |
Why?
|
Efficiency, Organizational | 5 | 2019 | 695 | 0.570 |
Why?
|
Interprofessional Relations | 6 | 2014 | 1011 | 0.570 |
Why?
|
Opiate Substitution Treatment | 1 | 2020 | 404 | 0.570 |
Why?
|
Attitude of Health Personnel | 9 | 2017 | 3841 | 0.560 |
Why?
|
Documentation | 3 | 2022 | 871 | 0.560 |
Why?
|
Blue Cross Blue Shield Insurance Plans | 8 | 2017 | 94 | 0.560 |
Why?
|
Insurance, Pharmaceutical Services | 3 | 2016 | 336 | 0.550 |
Why?
|
Antihypertensive Agents | 2 | 2023 | 2047 | 0.540 |
Why?
|
Cohort Studies | 22 | 2024 | 40559 | 0.530 |
Why?
|
Guideline Adherence | 4 | 2014 | 2265 | 0.520 |
Why?
|
Critical Care | 3 | 2021 | 2647 | 0.520 |
Why?
|
Formularies as Topic | 2 | 2007 | 91 | 0.520 |
Why?
|
Patient Acceptance of Health Care | 4 | 2019 | 3020 | 0.520 |
Why?
|
Communication Barriers | 1 | 2018 | 398 | 0.520 |
Why?
|
Patient Discharge | 8 | 2024 | 3318 | 0.520 |
Why?
|
Leukemia | 1 | 2023 | 1510 | 0.510 |
Why?
|
Hypertension | 6 | 2023 | 8479 | 0.510 |
Why?
|
Fees, Medical | 1 | 2015 | 117 | 0.510 |
Why?
|
Hip Fractures | 1 | 2023 | 955 | 0.510 |
Why?
|
Adult | 85 | 2023 | 214052 | 0.510 |
Why?
|
Middle Aged | 87 | 2024 | 213390 | 0.510 |
Why?
|
Laparotomy | 3 | 2015 | 473 | 0.500 |
Why?
|
Arthroplasty, Replacement, Hip | 2 | 2023 | 1462 | 0.500 |
Why?
|
Hospital Costs | 5 | 2020 | 985 | 0.490 |
Why?
|
Family Practice | 4 | 2007 | 516 | 0.490 |
Why?
|
Inpatients | 3 | 2022 | 2518 | 0.490 |
Why?
|
Substance Abuse Treatment Centers | 1 | 2015 | 168 | 0.490 |
Why?
|
Peer Group | 1 | 2019 | 635 | 0.480 |
Why?
|
Databases, Factual | 10 | 2020 | 7730 | 0.480 |
Why?
|
Colonoscopy | 5 | 2017 | 1367 | 0.480 |
Why?
|
Activities of Daily Living | 1 | 2023 | 2419 | 0.470 |
Why?
|
Health Benefit Plans, Employee | 6 | 2016 | 332 | 0.470 |
Why?
|
Risk Management | 2 | 2017 | 571 | 0.470 |
Why?
|
Disease Management | 8 | 2016 | 2460 | 0.460 |
Why?
|
Models, Educational | 2 | 2017 | 377 | 0.460 |
Why?
|
Mortality | 3 | 2021 | 2864 | 0.460 |
Why?
|
Diagnostic Imaging | 4 | 2016 | 3508 | 0.460 |
Why?
|
Hepatitis | 1 | 2015 | 227 | 0.460 |
Why?
|
Early Detection of Cancer | 6 | 2016 | 3086 | 0.450 |
Why?
|
Ontario | 7 | 2023 | 383 | 0.450 |
Why?
|
Cost Control | 8 | 2020 | 624 | 0.450 |
Why?
|
Motivation | 1 | 2022 | 1971 | 0.440 |
Why?
|
Analgesics, Opioid | 4 | 2019 | 3677 | 0.430 |
Why?
|
Benzodiazepines | 1 | 2019 | 1101 | 0.430 |
Why?
|
Buprenorphine | 1 | 2020 | 640 | 0.430 |
Why?
|
Episode of Care | 1 | 2013 | 126 | 0.430 |
Why?
|
Spine | 2 | 2019 | 1144 | 0.430 |
Why?
|
Internet | 4 | 2015 | 3056 | 0.430 |
Why?
|
Respiratory Tract Infections | 3 | 2017 | 961 | 0.430 |
Why?
|
Costs and Cost Analysis | 5 | 2023 | 1680 | 0.420 |
Why?
|
Hospital-Physician Joint Ventures | 1 | 2012 | 30 | 0.420 |
Why?
|
Health Plan Implementation | 1 | 2015 | 352 | 0.420 |
Why?
|
Drug Prescriptions | 2 | 2019 | 1637 | 0.410 |
Why?
|
Tissue Adhesions | 1 | 2013 | 235 | 0.410 |
Why?
|
Patient Care Planning | 1 | 2017 | 921 | 0.400 |
Why?
|
Medical Informatics | 2 | 2017 | 745 | 0.400 |
Why?
|
Antiretroviral Therapy, Highly Active | 7 | 2008 | 1872 | 0.390 |
Why?
|
Hospice Care | 2 | 2020 | 672 | 0.390 |
Why?
|
Hernia, Ventral | 2 | 2013 | 176 | 0.390 |
Why?
|
Terminal Care | 3 | 2020 | 1694 | 0.380 |
Why?
|
Vascular Grafting | 1 | 2012 | 143 | 0.380 |
Why?
|
Hypnotics and Sedatives | 1 | 2019 | 1162 | 0.380 |
Why?
|
Cardiovascular Diseases | 9 | 2023 | 15160 | 0.370 |
Why?
|
Pandemics | 2 | 2021 | 8385 | 0.370 |
Why?
|
Massachusetts | 18 | 2018 | 8662 | 0.370 |
Why?
|
Electronic Health Records | 6 | 2023 | 4468 | 0.360 |
Why?
|
Public Health Administration | 1 | 2012 | 240 | 0.360 |
Why?
|
Trust | 4 | 2011 | 505 | 0.360 |
Why?
|
Treatment Outcome | 22 | 2024 | 63107 | 0.350 |
Why?
|
Mental Health | 3 | 2023 | 3010 | 0.350 |
Why?
|
Medically Uninsured | 4 | 2009 | 853 | 0.350 |
Why?
|
Models, Organizational | 5 | 2015 | 574 | 0.340 |
Why?
|
Chi-Square Distribution | 7 | 2019 | 3508 | 0.340 |
Why?
|
Online Systems | 1 | 2010 | 184 | 0.340 |
Why?
|
Confusion | 1 | 2011 | 275 | 0.340 |
Why?
|
Postoperative Complications | 9 | 2022 | 15297 | 0.340 |
Why?
|
Rural Population | 2 | 2017 | 2207 | 0.340 |
Why?
|
Choice Behavior | 3 | 2011 | 802 | 0.340 |
Why?
|
Language | 1 | 2018 | 1471 | 0.340 |
Why?
|
Mass Screening | 8 | 2019 | 5253 | 0.330 |
Why?
|
Diffusion of Innovation | 2 | 2011 | 725 | 0.320 |
Why?
|
Australia | 2 | 2022 | 1167 | 0.320 |
Why?
|
Program Evaluation | 2 | 2015 | 2488 | 0.320 |
Why?
|
Insurance, Health, Reimbursement | 1 | 2011 | 397 | 0.300 |
Why?
|
Budgets | 3 | 2014 | 229 | 0.300 |
Why?
|
Aftercare | 2 | 2024 | 870 | 0.290 |
Why?
|
Private Practice | 1 | 2008 | 154 | 0.290 |
Why?
|
Socioeconomic Factors | 13 | 2023 | 7785 | 0.290 |
Why?
|
Decision Making | 6 | 2017 | 3888 | 0.290 |
Why?
|
Patient Participation | 3 | 2017 | 1457 | 0.290 |
Why?
|
Emergency Medical Services | 1 | 2018 | 1917 | 0.280 |
Why?
|
Critical Illness | 3 | 2018 | 2670 | 0.280 |
Why?
|
Length of Stay | 5 | 2023 | 6311 | 0.280 |
Why?
|
Organizational Innovation | 6 | 2016 | 559 | 0.270 |
Why?
|
Propensity Score | 6 | 2019 | 1781 | 0.270 |
Why?
|
Preventive Medicine | 3 | 2015 | 264 | 0.270 |
Why?
|
Surgicenters | 2 | 2017 | 46 | 0.270 |
Why?
|
HIV Infections | 17 | 2009 | 16715 | 0.270 |
Why?
|
Opioid-Related Disorders | 1 | 2020 | 2064 | 0.270 |
Why?
|
Coronary Artery Bypass | 4 | 2023 | 2288 | 0.270 |
Why?
|
Orthopedic Procedures | 1 | 2016 | 1289 | 0.260 |
Why?
|
Hypoglycemic Agents | 1 | 2018 | 2873 | 0.260 |
Why?
|
Regression Analysis | 10 | 2017 | 6459 | 0.260 |
Why?
|
Poverty | 5 | 2023 | 2660 | 0.260 |
Why?
|
Telemedicine | 3 | 2018 | 2872 | 0.260 |
Why?
|
Attitude to Health | 3 | 2011 | 2052 | 0.260 |
Why?
|
Benchmarking | 2 | 2019 | 1042 | 0.260 |
Why?
|
Population Surveillance | 3 | 2019 | 2616 | 0.250 |
Why?
|
Israel | 2 | 2022 | 796 | 0.250 |
Why?
|
Interinstitutional Relations | 2 | 2017 | 241 | 0.250 |
Why?
|
Organizational Culture | 3 | 2022 | 510 | 0.250 |
Why?
|
Education, Continuing | 1 | 2005 | 112 | 0.250 |
Why?
|
Cardiotonic Agents | 1 | 2007 | 535 | 0.250 |
Why?
|
Logistic Models | 14 | 2020 | 13409 | 0.230 |
Why?
|
Age Factors | 10 | 2019 | 18373 | 0.230 |
Why?
|
Risk Sharing, Financial | 3 | 2019 | 47 | 0.230 |
Why?
|
New York | 6 | 2023 | 886 | 0.230 |
Why?
|
Cost Sharing | 2 | 2020 | 407 | 0.230 |
Why?
|
Career Mobility | 1 | 2006 | 262 | 0.230 |
Why?
|
Advanced Practice Nursing | 1 | 2023 | 18 | 0.230 |
Why?
|
Life Expectancy | 2 | 2021 | 1184 | 0.230 |
Why?
|
Time Factors | 14 | 2020 | 40075 | 0.230 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 2 | 2022 | 1516 | 0.220 |
Why?
|
Malpractice | 2 | 2022 | 572 | 0.220 |
Why?
|
Employee Performance Appraisal | 1 | 2003 | 87 | 0.220 |
Why?
|
Fellowships and Scholarships | 2 | 2011 | 1078 | 0.220 |
Why?
|
Marketing of Health Services | 4 | 2011 | 153 | 0.220 |
Why?
|
Professional Practice | 2 | 2015 | 326 | 0.220 |
Why?
|
Patient Selection | 4 | 2021 | 4216 | 0.220 |
Why?
|
Health Policy | 5 | 2017 | 2661 | 0.220 |
Why?
|
Health Status | 6 | 2020 | 4034 | 0.220 |
Why?
|
Cholinergic Antagonists | 1 | 2023 | 165 | 0.210 |
Why?
|
Data Collection | 9 | 2014 | 3339 | 0.210 |
Why?
|
Young Adult | 19 | 2021 | 56429 | 0.210 |
Why?
|
Education, Medical, Graduate | 2 | 2013 | 2291 | 0.210 |
Why?
|
Quality Improvement | 6 | 2022 | 3749 | 0.210 |
Why?
|
Economics, Hospital | 3 | 2020 | 213 | 0.210 |
Why?
|
Fee Schedules | 1 | 2022 | 86 | 0.210 |
Why?
|
Risk Assessment | 8 | 2019 | 23336 | 0.210 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3135 | 0.210 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3242 | 0.210 |
Why?
|
Patient Care Team | 5 | 2017 | 2531 | 0.210 |
Why?
|
Organizations | 1 | 2022 | 170 | 0.200 |
Why?
|
Residence Characteristics | 5 | 2016 | 2050 | 0.200 |
Why?
|
Education, Medical, Continuing | 3 | 2008 | 840 | 0.200 |
Why?
|
Provider-Sponsored Organizations | 2 | 2016 | 13 | 0.200 |
Why?
|
Health Facilities, Proprietary | 1 | 2001 | 37 | 0.200 |
Why?
|
Interviews as Topic | 7 | 2017 | 2539 | 0.200 |
Why?
|
Equipment and Supplies, Hospital | 1 | 2021 | 57 | 0.200 |
Why?
|
Financing, Personal | 2 | 2016 | 308 | 0.200 |
Why?
|
Ambulatory Care Facilities | 4 | 2009 | 934 | 0.200 |
Why?
|
Odds Ratio | 7 | 2020 | 9849 | 0.190 |
Why?
|
Cooperative Behavior | 6 | 2016 | 1504 | 0.190 |
Why?
|
Syncope | 1 | 2024 | 429 | 0.190 |
Why?
|
Appointments and Schedules | 2 | 2023 | 417 | 0.190 |
Why?
|
Hospital Administration | 2 | 2017 | 353 | 0.190 |
Why?
|
Organizations, Nonprofit | 1 | 2001 | 104 | 0.190 |
Why?
|
Follow-Up Studies | 11 | 2024 | 39052 | 0.190 |
Why?
|
Health Knowledge, Attitudes, Practice | 7 | 2011 | 3922 | 0.190 |
Why?
|
Alzheimer Disease | 1 | 2021 | 8038 | 0.190 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2014 | 2020 | 0.190 |
Why?
|
Unnecessary Procedures | 2 | 2015 | 432 | 0.190 |
Why?
|
Multivariate Analysis | 9 | 2017 | 12244 | 0.180 |
Why?
|
Salaries and Fringe Benefits | 3 | 2018 | 264 | 0.180 |
Why?
|
Boston | 8 | 2013 | 9312 | 0.180 |
Why?
|
Reoperation | 4 | 2015 | 4201 | 0.180 |
Why?
|
Medical Records | 4 | 2017 | 1413 | 0.170 |
Why?
|
Mammography | 3 | 2015 | 2475 | 0.170 |
Why?
|
Severity of Illness Index | 6 | 2018 | 15535 | 0.170 |
Why?
|
Health Facility Merger | 1 | 2020 | 53 | 0.170 |
Why?
|
Patient Care Management | 1 | 2003 | 306 | 0.170 |
Why?
|
Biomedical Research | 3 | 2011 | 3309 | 0.170 |
Why?
|
Medical Oncology | 2 | 2023 | 2267 | 0.170 |
Why?
|
Health Promotion | 3 | 2020 | 2205 | 0.170 |
Why?
|
Outpatients | 2 | 2021 | 1487 | 0.170 |
Why?
|
Myocardial Revascularization | 1 | 2023 | 841 | 0.170 |
Why?
|
State Government | 2 | 2016 | 372 | 0.170 |
Why?
|
Self-Assessment | 1 | 2001 | 390 | 0.160 |
Why?
|
Calcium Channel Blockers | 1 | 2022 | 692 | 0.160 |
Why?
|
Incidence | 6 | 2019 | 20952 | 0.160 |
Why?
|
Housing | 1 | 2023 | 664 | 0.160 |
Why?
|
Internship and Residency | 3 | 2017 | 5791 | 0.160 |
Why?
|
Community Health Services | 2 | 2017 | 650 | 0.160 |
Why?
|
Terminally Ill | 1 | 2020 | 238 | 0.160 |
Why?
|
Insurance Benefits | 1 | 2019 | 183 | 0.150 |
Why?
|
Endoscopy | 1 | 2008 | 1787 | 0.150 |
Why?
|
Counseling | 2 | 2016 | 1523 | 0.150 |
Why?
|
Plant Leaves | 1 | 2018 | 143 | 0.150 |
Why?
|
Attitude | 1 | 2003 | 776 | 0.150 |
Why?
|
Sampling Studies | 3 | 2015 | 623 | 0.150 |
Why?
|
Clinical Trials, Phase III as Topic | 1 | 2021 | 841 | 0.150 |
Why?
|
Neoplasms | 4 | 2020 | 21696 | 0.150 |
Why?
|
Internationality | 1 | 2023 | 1002 | 0.150 |
Why?
|
Economics, Medical | 2 | 2007 | 113 | 0.150 |
Why?
|
Workplace | 2 | 2021 | 836 | 0.150 |
Why?
|
Physicians' Offices | 1 | 2017 | 58 | 0.150 |
Why?
|
Thienopyridines | 1 | 2016 | 12 | 0.150 |
Why?
|
Physician Executives | 2 | 2008 | 128 | 0.150 |
Why?
|
Syndrome | 1 | 2023 | 3252 | 0.150 |
Why?
|
Current Procedural Terminology | 1 | 2017 | 92 | 0.140 |
Why?
|
Cognition Disorders | 1 | 2011 | 4043 | 0.140 |
Why?
|
Patients | 2 | 2014 | 900 | 0.140 |
Why?
|
Oregon | 2 | 2007 | 140 | 0.140 |
Why?
|
Social Class | 3 | 2021 | 1997 | 0.140 |
Why?
|
Sulfonylurea Compounds | 1 | 2018 | 205 | 0.140 |
Why?
|
Risk Factors | 15 | 2024 | 72296 | 0.140 |
Why?
|
Canada | 4 | 2022 | 2065 | 0.140 |
Why?
|
Colorectal Neoplasms | 3 | 2016 | 6773 | 0.140 |
Why?
|
Pancreatectomy | 1 | 2021 | 804 | 0.140 |
Why?
|
Longitudinal Studies | 5 | 2017 | 13991 | 0.140 |
Why?
|
Comorbidity | 4 | 2022 | 10388 | 0.140 |
Why?
|
Peripheral Arterial Disease | 2 | 2017 | 1188 | 0.140 |
Why?
|
Mandatory Programs | 1 | 2016 | 87 | 0.140 |
Why?
|
Treatment Refusal | 2 | 2013 | 421 | 0.140 |
Why?
|
Adolescent | 21 | 2021 | 85779 | 0.140 |
Why?
|
England | 2 | 2016 | 522 | 0.130 |
Why?
|
Occult Blood | 3 | 2016 | 176 | 0.130 |
Why?
|
Social Support | 4 | 2016 | 2118 | 0.130 |
Why?
|
Supreme Court Decisions | 1 | 2016 | 128 | 0.130 |
Why?
|
Intestinal Perforation | 1 | 2017 | 253 | 0.130 |
Why?
|
Sex Factors | 4 | 2019 | 10400 | 0.130 |
Why?
|
Academic Medical Centers | 2 | 2017 | 2760 | 0.130 |
Why?
|
Nephrectomy | 1 | 2021 | 1050 | 0.130 |
Why?
|
Qualitative Research | 4 | 2017 | 2682 | 0.130 |
Why?
|
Drug Approval | 1 | 2021 | 742 | 0.130 |
Why?
|
Poliomyelitis | 1 | 2016 | 103 | 0.130 |
Why?
|
Ownership | 2 | 2012 | 332 | 0.130 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 7914 | 0.130 |
Why?
|
Pneumonia | 1 | 2006 | 2133 | 0.130 |
Why?
|
Neck Pain | 1 | 2016 | 180 | 0.120 |
Why?
|
Decompression, Surgical | 1 | 2019 | 594 | 0.120 |
Why?
|
Contract Services | 2 | 2011 | 94 | 0.120 |
Why?
|
Community Mental Health Services | 1 | 2017 | 386 | 0.120 |
Why?
|
Research | 2 | 2015 | 1999 | 0.120 |
Why?
|
Breast | 1 | 2023 | 1970 | 0.120 |
Why?
|
Intermittent Claudication | 1 | 2016 | 309 | 0.120 |
Why?
|
Early Diagnosis | 1 | 2019 | 1184 | 0.120 |
Why?
|
Hospital Bed Capacity | 1 | 2015 | 215 | 0.120 |
Why?
|
Diagnostic Errors | 1 | 2021 | 1257 | 0.120 |
Why?
|
United States Food and Drug Administration | 1 | 2021 | 1584 | 0.120 |
Why?
|
Aorta, Abdominal | 1 | 2016 | 646 | 0.120 |
Why?
|
Shock, Septic | 1 | 2020 | 775 | 0.110 |
Why?
|
Veterans Health | 1 | 2015 | 216 | 0.110 |
Why?
|
Medicare Assignment | 1 | 2013 | 9 | 0.110 |
Why?
|
AIDS-Related Opportunistic Infections | 3 | 2007 | 657 | 0.110 |
Why?
|
Linear Models | 8 | 2021 | 5953 | 0.110 |
Why?
|
Diagnostic Techniques and Procedures | 2 | 2016 | 214 | 0.110 |
Why?
|
Burnout, Professional | 1 | 2022 | 694 | 0.110 |
Why?
|
Heart Failure | 2 | 2007 | 10895 | 0.110 |
Why?
|
Patient Preference | 1 | 2020 | 889 | 0.110 |
Why?
|
Coronary Disease | 1 | 2007 | 6077 | 0.110 |
Why?
|
Models, Theoretical | 2 | 2015 | 3589 | 0.110 |
Why?
|
Diagnostic Tests, Routine | 1 | 2018 | 783 | 0.110 |
Why?
|
Blood Vessel Prosthesis | 1 | 2017 | 934 | 0.110 |
Why?
|
Independent Practice Associations | 3 | 2002 | 20 | 0.110 |
Why?
|
Minnesota | 4 | 2005 | 344 | 0.110 |
Why?
|
Education, Medical | 2 | 2007 | 1722 | 0.100 |
Why?
|
Prostatectomy | 1 | 2021 | 1890 | 0.100 |
Why?
|
Acute Disease | 3 | 2015 | 7147 | 0.100 |
Why?
|
Health Facility Size | 1 | 2012 | 64 | 0.100 |
Why?
|
Utilization Review | 3 | 2013 | 392 | 0.100 |
Why?
|
Drug Utilization | 2 | 2016 | 1183 | 0.100 |
Why?
|
Family | 2 | 2022 | 3147 | 0.100 |
Why?
|
Medical Records Systems, Computerized | 2 | 2008 | 1205 | 0.100 |
Why?
|
Stents | 2 | 2017 | 3282 | 0.100 |
Why?
|
Health Facilities | 1 | 2016 | 572 | 0.100 |
Why?
|
Prospective Payment System | 1 | 2012 | 133 | 0.100 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2015 | 500 | 0.100 |
Why?
|
Models, Econometric | 2 | 2017 | 218 | 0.100 |
Why?
|
Metformin | 1 | 2018 | 836 | 0.090 |
Why?
|
Communication | 4 | 2022 | 3750 | 0.090 |
Why?
|
Trauma Severity Indices | 1 | 2012 | 481 | 0.090 |
Why?
|
Survival Rate | 3 | 2019 | 12788 | 0.090 |
Why?
|
Protease Inhibitors | 2 | 2004 | 791 | 0.090 |
Why?
|
Registries | 3 | 2022 | 8091 | 0.090 |
Why?
|
Spinal Fusion | 1 | 2019 | 1241 | 0.090 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2015 | 455 | 0.090 |
Why?
|
Hospitals, Urban | 1 | 2012 | 499 | 0.090 |
Why?
|
Continuity of Patient Care | 3 | 2013 | 1049 | 0.090 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2017 | 1131 | 0.090 |
Why?
|
Breast Neoplasms | 4 | 2015 | 20824 | 0.090 |
Why?
|
Blood Pressure | 2 | 2023 | 8551 | 0.090 |
Why?
|
Developing Countries | 1 | 2022 | 2815 | 0.090 |
Why?
|
Heart-Assist Devices | 1 | 2020 | 1195 | 0.090 |
Why?
|
Physical Therapy Modalities | 1 | 2013 | 550 | 0.090 |
Why?
|
Cost-Benefit Analysis | 4 | 2020 | 5388 | 0.090 |
Why?
|
Acetaminophen | 1 | 2013 | 545 | 0.090 |
Why?
|
Physician's Role | 2 | 2012 | 943 | 0.090 |
Why?
|
Computer Simulation | 2 | 2020 | 6194 | 0.080 |
Why?
|
Search Engine | 1 | 2010 | 144 | 0.080 |
Why?
|
Patient Compliance | 2 | 2011 | 2684 | 0.080 |
Why?
|
Lower Extremity | 1 | 2016 | 1158 | 0.080 |
Why?
|
Child | 10 | 2023 | 77709 | 0.080 |
Why?
|
Perception | 2 | 2017 | 1198 | 0.080 |
Why?
|
Group Purchasing | 1 | 2007 | 11 | 0.080 |
Why?
|
Medically Underserved Area | 2 | 2007 | 253 | 0.080 |
Why?
|
Morbidity | 1 | 2013 | 1768 | 0.080 |
Why?
|
Child Health Services | 1 | 2013 | 667 | 0.080 |
Why?
|
Substance-Related Disorders | 2 | 2018 | 4257 | 0.080 |
Why?
|
Enema | 1 | 2008 | 141 | 0.080 |
Why?
|
Sigmoidoscopy | 1 | 2008 | 156 | 0.080 |
Why?
|
Reminder Systems | 1 | 2011 | 371 | 0.080 |
Why?
|
Insurance, Hospitalization | 1 | 2007 | 30 | 0.080 |
Why?
|
Ischemia | 1 | 2016 | 1907 | 0.080 |
Why?
|
Government Regulation | 1 | 2012 | 522 | 0.070 |
Why?
|
General Surgery | 1 | 2019 | 1636 | 0.070 |
Why?
|
Health Care Coalitions | 1 | 2007 | 35 | 0.070 |
Why?
|
Pilot Projects | 2 | 2010 | 8319 | 0.070 |
Why?
|
Case Management | 2 | 2009 | 286 | 0.070 |
Why?
|
Kaplan-Meier Estimate | 2 | 2016 | 6539 | 0.070 |
Why?
|
Commerce | 2 | 2013 | 592 | 0.070 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 2018 | 1458 | 0.070 |
Why?
|
Awareness | 1 | 2011 | 640 | 0.070 |
Why?
|
Intraoperative Complications | 2 | 2017 | 1198 | 0.070 |
Why?
|
Psychiatry | 1 | 2019 | 1695 | 0.070 |
Why?
|
Prescription Fees | 1 | 2007 | 146 | 0.070 |
Why?
|
Drug Utilization Review | 1 | 2007 | 245 | 0.070 |
Why?
|
Demography | 1 | 2011 | 1655 | 0.070 |
Why?
|
Health Personnel | 3 | 2015 | 3219 | 0.070 |
Why?
|
Evaluation Studies as Topic | 1 | 2008 | 1681 | 0.070 |
Why?
|
Sensitivity and Specificity | 3 | 2017 | 14723 | 0.070 |
Why?
|
Cognition | 1 | 2023 | 6770 | 0.070 |
Why?
|
Vaccination | 2 | 2016 | 3279 | 0.070 |
Why?
|
Nurses | 1 | 2015 | 2462 | 0.070 |
Why?
|
Hospitals, Teaching | 2 | 2009 | 1180 | 0.070 |
Why?
|
Medical Audit | 1 | 2007 | 467 | 0.070 |
Why?
|
Quality Control | 1 | 2008 | 841 | 0.070 |
Why?
|
Pharmaceutical Preparations | 1 | 2014 | 1070 | 0.060 |
Why?
|
Palliative Care | 1 | 2020 | 3493 | 0.060 |
Why?
|
Safety | 1 | 2010 | 1186 | 0.060 |
Why?
|
Hospitals, Chronic Disease | 1 | 2004 | 8 | 0.060 |
Why?
|
Vaginal Smears | 1 | 2008 | 511 | 0.060 |
Why?
|
Professional Autonomy | 2 | 2004 | 177 | 0.060 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 2005 | 2232 | 0.060 |
Why?
|
ROC Curve | 2 | 2011 | 3528 | 0.060 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2019 | 3338 | 0.060 |
Why?
|
Florida | 2 | 2017 | 435 | 0.060 |
Why?
|
Aspirin | 1 | 2016 | 3283 | 0.060 |
Why?
|
Endoscopy, Gastrointestinal | 1 | 2010 | 868 | 0.060 |
Why?
|
Organizational Case Studies | 3 | 2012 | 299 | 0.060 |
Why?
|
Patient Transfer | 1 | 2011 | 762 | 0.060 |
Why?
|
Physicians, Women | 1 | 2010 | 486 | 0.060 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2016 | 3070 | 0.060 |
Why?
|
Statistics as Topic | 1 | 2010 | 2373 | 0.060 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 1 | 2013 | 2282 | 0.060 |
Why?
|
Mental Disorders | 2 | 2017 | 6598 | 0.060 |
Why?
|
Algorithms | 3 | 2014 | 13882 | 0.060 |
Why?
|
Nursing Staff, Hospital | 1 | 2006 | 346 | 0.060 |
Why?
|
Disease-Free Survival | 1 | 2013 | 6896 | 0.060 |
Why?
|
Practice Guidelines as Topic | 3 | 2015 | 7282 | 0.050 |
Why?
|
Risk | 1 | 2015 | 9688 | 0.050 |
Why?
|
Child, Preschool | 7 | 2016 | 41005 | 0.050 |
Why?
|
Practice Management | 1 | 2003 | 37 | 0.050 |
Why?
|
Clinical Medicine | 1 | 2004 | 147 | 0.050 |
Why?
|
New Zealand | 1 | 2023 | 355 | 0.050 |
Why?
|
Migraine Disorders | 1 | 2015 | 1620 | 0.050 |
Why?
|
Analysis of Variance | 2 | 2001 | 6366 | 0.050 |
Why?
|
Infant | 6 | 2016 | 35134 | 0.050 |
Why?
|
Parents | 1 | 2016 | 3405 | 0.050 |
Why?
|
Wound Healing | 1 | 2013 | 2785 | 0.050 |
Why?
|
Age Distribution | 1 | 2008 | 2902 | 0.050 |
Why?
|
Patient Education as Topic | 2 | 2010 | 2278 | 0.050 |
Why?
|
Lipid Regulating Agents | 1 | 2021 | 24 | 0.050 |
Why?
|
Vaginal Discharge | 1 | 2001 | 25 | 0.050 |
Why?
|
Social Responsibility | 1 | 2004 | 388 | 0.050 |
Why?
|
New South Wales | 1 | 2021 | 66 | 0.050 |
Why?
|
Employment | 1 | 2007 | 1132 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3611 | 0.050 |
Why?
|
Models, Statistical | 4 | 2021 | 5101 | 0.050 |
Why?
|
Low Back Pain | 1 | 2009 | 956 | 0.050 |
Why?
|
Pediatrics | 1 | 2015 | 3475 | 0.050 |
Why?
|
Substance Abuse, Intravenous | 1 | 2005 | 525 | 0.050 |
Why?
|
Arizona | 1 | 2019 | 108 | 0.040 |
Why?
|
Curriculum | 1 | 2013 | 3605 | 0.040 |
Why?
|
Women's Health | 2 | 2007 | 2034 | 0.040 |
Why?
|
Predictive Value of Tests | 3 | 2018 | 15078 | 0.040 |
Why?
|
Economic Competition | 1 | 2001 | 214 | 0.040 |
Why?
|
Maintenance | 1 | 2019 | 25 | 0.040 |
Why?
|
Health Services Administration | 1 | 2000 | 64 | 0.040 |
Why?
|
HIV Seropositivity | 1 | 2005 | 971 | 0.040 |
Why?
|
Self Care | 1 | 2004 | 786 | 0.040 |
Why?
|
Information Systems | 1 | 2001 | 410 | 0.040 |
Why?
|
Colonic Neoplasms | 1 | 2011 | 2542 | 0.040 |
Why?
|
Infant, Newborn | 3 | 2016 | 25628 | 0.040 |
Why?
|
Research Design | 3 | 2011 | 5984 | 0.040 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7182 | 0.040 |
Why?
|
Rhode Island | 1 | 2019 | 347 | 0.040 |
Why?
|
Prevalence | 1 | 2015 | 15221 | 0.040 |
Why?
|
Reproducibility of Results | 6 | 2019 | 19905 | 0.040 |
Why?
|
New England | 2 | 2011 | 1022 | 0.040 |
Why?
|
Feedback | 1 | 2002 | 795 | 0.040 |
Why?
|
Planning Techniques | 1 | 1998 | 82 | 0.040 |
Why?
|
Cholesterol, LDL | 2 | 2019 | 2355 | 0.040 |
Why?
|
Attitude to Death | 1 | 2020 | 382 | 0.040 |
Why?
|
Personal Satisfaction | 1 | 2022 | 643 | 0.040 |
Why?
|
Prostatic Hyperplasia | 1 | 2001 | 523 | 0.040 |
Why?
|
Hypolipidemic Agents | 1 | 2002 | 604 | 0.040 |
Why?
|
Urban Health Services | 1 | 2017 | 179 | 0.040 |
Why?
|
Mental Health Services | 1 | 2008 | 1644 | 0.040 |
Why?
|
Sex Characteristics | 1 | 2007 | 2585 | 0.030 |
Why?
|
Annual Reports as Topic | 1 | 2015 | 33 | 0.030 |
Why?
|
Poverty Areas | 1 | 2017 | 275 | 0.030 |
Why?
|
Specialties, Surgical | 1 | 2001 | 391 | 0.030 |
Why?
|
Prospective Studies | 5 | 2020 | 53290 | 0.030 |
Why?
|
Insurance | 1 | 2017 | 111 | 0.030 |
Why?
|
Private Sector | 1 | 2018 | 392 | 0.030 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 11726 | 0.030 |
Why?
|
Viral Load | 1 | 2004 | 3300 | 0.030 |
Why?
|
Guidelines as Topic | 1 | 2002 | 1405 | 0.030 |
Why?
|
Hypercholesterolemia | 1 | 2001 | 1151 | 0.030 |
Why?
|
Medical Errors | 1 | 2022 | 1297 | 0.030 |
Why?
|
Rural Health Services | 1 | 2017 | 379 | 0.030 |
Why?
|
Matched-Pair Analysis | 1 | 2013 | 288 | 0.030 |
Why?
|
Proportional Hazards Models | 2 | 2017 | 12356 | 0.030 |
Why?
|
Asthma | 2 | 2009 | 6010 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 1 | 2015 | 20130 | 0.030 |
Why?
|
Prostate-Specific Antigen | 1 | 2001 | 2494 | 0.020 |
Why?
|
Renal Insufficiency | 1 | 2017 | 804 | 0.020 |
Why?
|
Family Characteristics | 1 | 2016 | 1000 | 0.020 |
Why?
|
Cause of Death | 1 | 2021 | 3582 | 0.020 |
Why?
|
Small-Area Analysis | 1 | 2010 | 55 | 0.020 |
Why?
|
Holistic Health | 1 | 2010 | 47 | 0.020 |
Why?
|
Information Storage and Retrieval | 1 | 2015 | 824 | 0.020 |
Why?
|
Information Seeking Behavior | 1 | 2010 | 113 | 0.020 |
Why?
|
India | 1 | 2016 | 2197 | 0.020 |
Why?
|
Cluster Analysis | 1 | 2016 | 2715 | 0.020 |
Why?
|
Confidence Intervals | 2 | 2006 | 2971 | 0.020 |
Why?
|
Management Quality Circles | 1 | 2007 | 21 | 0.020 |
Why?
|
Health Status Disparities | 2 | 2010 | 1796 | 0.020 |
Why?
|
Magnetic Resonance Imaging | 1 | 2015 | 35425 | 0.020 |
Why?
|
Interpersonal Relations | 1 | 2015 | 1425 | 0.020 |
Why?
|
Decision Making, Organizational | 1 | 2007 | 139 | 0.020 |
Why?
|
Pneumocystis carinii | 1 | 2007 | 74 | 0.020 |
Why?
|
Vaccines | 1 | 2016 | 823 | 0.020 |
Why?
|
Leadership | 1 | 2016 | 1357 | 0.020 |
Why?
|
Community-Based Participatory Research | 1 | 2009 | 214 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 2010 | 423 | 0.020 |
Why?
|
Area Under Curve | 1 | 2011 | 1655 | 0.020 |
Why?
|
Endocrine System Diseases | 1 | 2009 | 248 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2016 | 6489 | 0.020 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2007 | 249 | 0.020 |
Why?
|
Poisson Distribution | 1 | 2007 | 513 | 0.020 |
Why?
|
Health Literacy | 1 | 2010 | 414 | 0.020 |
Why?
|
Focus Groups | 1 | 2010 | 1321 | 0.020 |
Why?
|
Federal Government | 1 | 2006 | 260 | 0.020 |
Why?
|
Professional-Patient Relations | 1 | 2010 | 737 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2013 | 21748 | 0.020 |
Why?
|
HIV Protease Inhibitors | 1 | 2007 | 430 | 0.020 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2019 | 3255 | 0.020 |
Why?
|
Capital Financing | 1 | 2004 | 58 | 0.010 |
Why?
|
Needs Assessment | 1 | 2010 | 1147 | 0.010 |
Why?
|
Selection Bias | 1 | 2005 | 371 | 0.010 |
Why?
|
Financing, Government | 1 | 2006 | 468 | 0.010 |
Why?
|
Financial Management | 1 | 2004 | 160 | 0.010 |
Why?
|
Urban Population | 1 | 2010 | 2022 | 0.010 |
Why?
|
Information Services | 1 | 2001 | 244 | 0.010 |
Why?
|
Prejudice | 1 | 2004 | 570 | 0.010 |
Why?
|
Prognosis | 2 | 2002 | 29060 | 0.010 |
Why?
|
Health Behavior | 1 | 2010 | 2635 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2004 | 2887 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 1 | 2005 | 2560 | 0.010 |
Why?
|
Diagnosis-Related Groups | 1 | 2000 | 455 | 0.010 |
Why?
|
Health Care Sector | 1 | 2000 | 194 | 0.010 |
Why?
|
Medication Adherence | 1 | 2009 | 2063 | 0.010 |
Why?
|
Factor Analysis, Statistical | 1 | 2000 | 977 | 0.010 |
Why?
|
Primary Prevention | 1 | 2004 | 1167 | 0.010 |
Why?
|
Teaching | 1 | 2004 | 1174 | 0.010 |
Why?
|
Data Interpretation, Statistical | 1 | 2006 | 2716 | 0.010 |
Why?
|
Cholesterol | 1 | 2004 | 2919 | 0.010 |
Why?
|
Secondary Prevention | 1 | 2002 | 1530 | 0.010 |
Why?
|
Tuberculosis | 1 | 2007 | 1912 | 0.010 |
Why?
|
Forecasting | 1 | 2004 | 2951 | 0.010 |
Why?
|
Research Personnel | 1 | 2000 | 573 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2009 | 12961 | 0.010 |
Why?
|